@article{JTD24456,
author = {Eric A. Hoste and Wim Vandenberghe},
title = {Plasma neutrophil gelatinase-associated lipocalin (NGAL) for timing of initiation of renal replacement therapy for acute kidney injury?},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 33},
year = {2018},
keywords = {},
abstract = {Renal replacement therapy (RRT) for acute kidney injury (AKI) has been in use in critically ill patient since the first successful treatments done by William Kolff during the mid-1940-ties (1). Similar to many other invasive treatments used in the intensive care unit (ICU) such as mechanical ventilation, decompressive craniotomy, or intra-aortic balloon pump and despite over 6 decades of experience, the optimal timing of initiation of RRT for AKI is still a matter of debate (2).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/24456}
}